Next-generation personalized drug discovery: the tripeptide GHK hits center stage in chronic obstructive pulmonary disease

Chronic lung diseases (CLDs), including chronic obstructive pulmonary disease (COPD), are the second leading cause of death worldwide. The first report of database-driven drug discovery in carefully phenotyped COPD specimens has now been published in Genome Medicine, combining gene expression data i...

Descripción completa

Detalles Bibliográficos
Autores principales: Meiners, Silke, Eickelberg, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580440/
https://www.ncbi.nlm.nih.gov/pubmed/22999295
http://dx.doi.org/10.1186/gm371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580440/
https://www.ncbi.nlm.nih.gov/pubmed/22999295
http://dx.doi.org/10.1186/gm371

Ejemplares similares